Literature DB >> 23801193

Expression of pituitary adenylate cyclase-activating peptide (PACAP) and PAC1 in the periodontal ligament after tooth luxation.

Sayako Nonaka1, Hideki Kitaura, Keisuke Kimura, Masahiko Ishida, Teruko Takano-Yamamoto.   

Abstract

Pituitary adenylate cyclase-activating peptide (PACAP) is widely distributed throughout the nervous system. PACAP not only acts as a neurotransmitter but also elicits a broad spectrum of biological action via the PACAP-specific receptor, PAC1. However, no studies have investigated PACAP and PAC1 in the periodontal ligament (PDL), so we aimed to perform this investigation in rats after tooth luxation. In the PDL of an intact first molar, there are few osteoclasts and osteoblasts. However, at days 3 and 5 after luxation, large PAC1-positive cells, thought to be osteoclasts because of their expression of the osteoclast marker, tartrate-resistant acid phosphatase, were detected in appreciable numbers. Osteoblast numbers increased dramatically on day 7 after luxation, and PAC1-positive mononuclear small cells were increased at day 14, many of which expressed the osteoblast marker, alkaline phosphatase. PACAP-positive nerve fibers were rarely detected in the PDL of intact first molars, but were increasingly evident at this site on days 5 and 7 after luxation. Double-immunofluorescence analysis demonstrated the relationship between PACAP-positive nerve fibers and PAC1-positive osteoclasts/-blasts in the PDL. At 5 days after luxation, PACAP-positive nerve fibers appeared in close proximity to PAC1-positive osteoclasts. At 7 days after luxation, PACAP-positive nerve fibers appeared in close proximity to PAC1-positive osteoblasts. These results suggest that PACAP may have effects on osteoclasts and osteoblasts in the PDL after tooth luxation and thus regulate bone remodeling after these types of injury.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23801193     DOI: 10.1007/s10571-013-9953-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  44 in total

1.  Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors.

Authors:  M Lee; V Lelievre; P Zhao; M Torres; W Rodriguez; J Y Byun; S Doshi; Y Ioffe; G Gupta; A E de los Monteros; J de Vellis; J Waschek
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

2.  The distribution of vasoactive intestinal polypeptides and calcitonin gene-related peptide in the periodontal ligament of mouse molar teeth.

Authors:  J Kato; H Ichikawa; S Wakisaka; S Matsuo; M Sakuda; M Akai
Journal:  Arch Oral Biol       Date:  1990       Impact factor: 2.633

3.  Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27) and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis.

Authors:  M Delgado; E Garrido; C Martinez; J Leceta; R P Gomariz
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

4.  Impaired nerve regeneration and enhanced neuroinflammatory response in mice lacking pituitary adenylyl cyclase activating peptide.

Authors:  B D Armstrong; C Abad; S Chhith; G Cheung-Lau; O E Hajji; H Nobuta; J A Waschek
Journal:  Neuroscience       Date:  2007-10-30       Impact factor: 3.590

Review 5.  Gut/brain peptides in the genital tract: VIP and PACAP.

Authors:  J Fahrenkrug
Journal:  Scand J Clin Lab Invest Suppl       Date:  2001

Review 6.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

7.  The axotomy-induced neuropeptides galanin and pituitary adenylate cyclase-activating peptide promote axonal sprouting of primary afferent and cranial motor neurones.

Authors:  Victor Suarez; Orlando Guntinas-Lichius; Michael Streppel; Shota Ingorokva; Maria Grosheva; Wolfram F Neiss; Doychin N Angelov; Lars Klimaschewski
Journal:  Eur J Neurosci       Date:  2006-09       Impact factor: 3.386

8.  Pituitary adenylate cyclase-activating polypeptide promotes the survival of basal forebrain cholinergic neurons in vitro and in vivo: comparison with effects of nerve growth factor.

Authors:  N Takei; E Torres; A Yuhara; H Jongsma; C Otto; L Korhonen; Y Abiru; Y Skoglösa; G Schütz; H Hatanaka; M V Sofroniew; D Lindholm
Journal:  Eur J Neurosci       Date:  2000-07       Impact factor: 3.386

9.  Pituitary adenylate cyclase-activating polypeptide induces cAMP production independently from vasoactive intestinal polypeptide in osteoblast-like cells.

Authors:  A Suzuki; J Kotoyori; Y Oiso; O Kozawa
Journal:  Cell Signal       Date:  1994-01       Impact factor: 4.315

10.  Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP).

Authors:  P E Gottschall; I Tatsuno; A Arimura
Journal:  Brain Res       Date:  1994-02-21       Impact factor: 3.252

View more
  3 in total

1.  Structural and morphometric comparison of the molar teeth in pre-eruptive developmental stage of PACAP-deficient and wild-type mice.

Authors:  B Sandor; K Fintor; Sz Felszeghy; T Juhasz; D Reglodi; L Mark; P Kiss; A Jungling; B D Fulop; A D Nagy; H Hashimoto; R Zakany; A Nagy; A Tamas
Journal:  J Mol Neurosci       Date:  2014-08-12       Impact factor: 3.444

2.  Structural and Morphometric Comparison of Lower Incisors in PACAP-Deficient and Wild-Type Mice.

Authors:  B Sandor; K Fintor; D Reglodi; D B Fulop; Z Helyes; I Szanto; P Nagy; H Hashimoto; A Tamas
Journal:  J Mol Neurosci       Date:  2016-05-06       Impact factor: 3.444

Review 3.  Do Neuroendocrine Peptides and Their Receptors Qualify as Novel Therapeutic Targets in Osteoarthritis?

Authors:  Susanne Grässel; Dominique Muschter
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.